Beta Blocker Use Ranges From 60-70% In Managed Care Plans - NCQA
Executive Summary
Beta blocker administration following heart attack ranged from 60%-90% of managed care enrollees during 1997, depending on the region in which the plan is based, according to the National Committee for Quality Assurance.